News

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
A non-reactive result in an HIV test generally means that you don't have HIV. It may also mean you tested too soon after ...
The Maine Center for Disease Control has identified two more positive HIV cases in Penobscot County, bringing the total cases ...
Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.
The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and prevention methods.
People with HIV face nearly three times the risk of subclinical obstructive coronary atherosclerosis, even with comparable cardiovascular risk profiles, new imaging data reveal.
Merck will share new scientific findings from its HIV clinical development programs, including Phase 2 data on the safety and pharmacokinetics of MK-8527, an investigational, novel nucleoside reverse ...